Lise Eliot

Lise Eliot has a significant amount of work experience in the pharmaceutical industry. Lise'smost recent role is as the Executive Director of Medical Writing at Intercept Pharmaceuticals, a position they have held since February 2022. Prior to that, they worked as the Senior Director at Marker Therapeutics, Inc. from April 2021 to February 2022. From May 2019 to April 2021, Lise Eliot served as the Senior Director of Medical Writing at Turning Point Therapeutics. Lise also held the position of Head of Development Writing at Samorn Biosciences from July 2018 to May 2019. Before that, they worked as the Senior Director of Clinical Development at Arena Pharmaceuticals, Inc. from August 2017 to August 2018. Lise Eliot gained valuable experience at Intercept Pharmaceuticals from June 2008 to June 2016 in the role of Clinical Science and Pharmacology. Prior to that, they worked as the President and Clinical Science and Pharmacology Consultant at LKAN Clinical from June 2006 to June 2009. Lise'searly career includes a role as the Manager of Clinical Science at Elan Pharmaceuticals from January 2003 to April 2005.

Lise Eliot obtained a Doctor of Philosophy - PhD in Pharmaceutical Sciences from the Faculty of Pharmacy and Pharmaceutical Sciences at the University of Alberta in 1998. Lise also pursued another Doctor of Philosophy - PhD in Pharmaceutical Sciences from the University of Alberta. However, the start and end years for this second degree are not provided.